International Biotechnology Trust PLC Vera Therapeutics, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 758,355 shares of VERA stock, worth $18.4 Million. This represents 3.53% of its overall portfolio holdings.
Number of Shares
758,355
Previous 975,227
22.24%
Holding current value
$18.4 Million
Previous $15.7 Million
33.57%
% of portfolio
3.53%
Previous 4.88%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Avoro Capital Advisors LLC New York, NY6.3MShares$153 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$109 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$83.1 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$81.2 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$80.9 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $656M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...